Daniel Catovsky

Daniel Catovsky

UNVERIFIED PROFILE

Are you Daniel Catovsky?   Register this Author

Register author
Daniel Catovsky

Daniel Catovsky

Publications by authors named "Daniel Catovsky"

Are you Daniel Catovsky?   Register this Author

100Publications

796Reads

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Nat Commun 2017 02 6;8:14175. Epub 2017 Feb 6.

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article
February 2017

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Br J Haematol 2016 Sep 6;174(5):767-75. Epub 2016 May 6.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article
September 2016

Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.

Cell Rep 2016 08 11;16(8):2061-2067. Epub 2016 Aug 11.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SW7 3RP, UK. Electronic address:

View Article
August 2016

Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.

Cancer Res 2016 Mar;76(6):1485-1493

Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK and Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.

View Article
March 2016

The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.

Br J Haematol 2016 Jan 12;172(2):228-37. Epub 2015 Oct 12.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article
January 2016

An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy.

Br J Haematol 2015 Dec 25;171(5):784-7. Epub 2015 Sep 25.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article
December 2015

Long-term follow-up after purine analogue therapy in hairy cell leukaemia.

Best Pract Res Clin Haematol 2015 Dec 9;28(4):217-29. Epub 2015 Oct 9.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address:

View Article
December 2015

The clinical significance of patients' sex in chronic lymphocytic leukemia.

Haematologica 2014 Jun 21;99(6):1088-94. Epub 2014 Mar 21.

Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London.

View Article
June 2014

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.

Haematologica 2013 Feb 16;98(2):274-8. Epub 2012 Aug 16.

Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article
February 2013

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.

Br J Haematol 2012 Nov 27;159(3):322-8. Epub 2012 Sep 27.

Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.

View Article
November 2012

The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.

Br J Haematol 2012 Aug 18;158(3):347-54. Epub 2012 May 18.

The Institute of Cancer Research & The Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK.

View Article
August 2012

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.

Leuk Lymphoma 2012 Jul 1;53(7):1289-98. Epub 2012 Mar 1.

Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, Sutton, UK.

View Article
July 2012

Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*.

Br J Haematol 2012 Jan 24;156(2):186-95. Epub 2011 Nov 24.

Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

View Article
January 2012

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.

Leuk Lymphoma 2011 Jun;52 Suppl 2:21-4

Department of Haemato-Oncology, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

View Article
June 2011

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.

Cancer 2011 Jun 14;117(11):2452-60. Epub 2010 Dec 14.

Section of Haemato-Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.

View Article
June 2011

Chlorambucil--still not bad: a reappraisal.

Clin Lymphoma Myeloma Leuk 2011 Jun 6;11 Suppl 1:S2-6. Epub 2011 May 6.

Section of Haemato-Oncology, The Institute of Cancer Research, Sutton, United Kingdom.

View Article
June 2011

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.

Haematologica 2010 Oct 29;95(10):1705-12. Epub 2010 May 29.

Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.

View Article
October 2010

Diagnostic issues in chronic lymphocytic leukaemia (CLL).

Best Pract Res Clin Haematol 2010 Mar;23(1):3-20

Section of Haemato-Oncology Department, The Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK.

View Article
March 2010

Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia.

Blood 2009 Nov 7;114(23):4843-6. Epub 2009 Oct 7.

Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton, United Kingdom.

View Article
November 2009

Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.

Br J Haematol 2008 Dec 18;143(5):690-7. Epub 2008 Oct 18.

Section of Haemato-Oncology, The Institute of Cancer Research, Sutton, Surrey, UK.

View Article
December 2008

Disease burden of chronic lymphocytic leukaemia within the European Union.

Eur J Haematol 2008 Oct 8;81(4):253-8. Epub 2008 Jul 8.

Louise Watson Consulting Ltd, Buxton, UK.

View Article
October 2008

Familial chronic lymphocytic leukemia.

Curr Hematol Malig Rep 2008 Oct;3(4):221-5

Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

View Article
October 2008

Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.

Blood 2008 Feb 15;111(3):1625-33. Epub 2007 Nov 15.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article
February 2008

Lack of a relationship between the common 18q24 variant rs12953717 and risk of chronic lymphocytic leukemia.

Leuk Lymphoma 2008 Feb;49(2):271-2

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article
February 2008

Obituary. David Abraham Goitein Galton.

Leuk Lymphoma 2007 Dec;48(12):2277-8

View Article
December 2007

The changing face of chronic lymphocytic leukemia.

Authors:
Daniel Catovsky

Leuk Lymphoma 2007 Dec;48(12):2283-4

Section of Haemato-Oncology, Institute of Cancer Research, Surrey, UK.

View Article
December 2007

Differential diagnosis in chronic lymphocytic leukaemia.

Best Pract Res Clin Haematol 2007 Sep;20(3):367-84

Haemato-Oncology Department, The Royal Marsden Hospital and Institute of Cancer Research, 203 Fulham Road, London SW3 6JJ, UK.

View Article
September 2007

Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia.

Leuk Res 2006 Dec 3;30(12):1573-6. Epub 2006 Apr 3.

Section of Cancer Genetics, Brooks Lawley Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article
December 2006

Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.

Blood 2006 Jul 30;108(2):638-44. Epub 2006 Mar 30.

Sections of Cancer Genetics and Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK.

View Article
July 2006

Familial chronic lymphocytic leukemia.

Semin Oncol 2006 Apr;33(2):195-201

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.

View Article
April 2006

Familial cancer associated with a polymorphism in ARLTS1.

N Engl J Med 2006 Mar;354(11):1204-5; author reply 1204-5

View Article
March 2006

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.

Cancer 2005 Dec;104(11):2442-8

Section of Haemato-Oncology, Royal Marsden NHS Foundation Trust/Institute of Cancer Research (ICR), Sutton, United Kingdom.

View Article
December 2005

Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review.

Am J Surg Pathol 2005 Jul;29(7):935-41

Section of Haemato-Oncology, Royal Marsden Hospital Foundation Trust/Institute of Cancer Research, London UK.

View Article
July 2005

Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia.

Br J Haematol 2005 Mar;128(5):645-8

Section of Haemato-Oncology, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, Surrey SM2 5PT, UK.

View Article
March 2005

Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment.

Leuk Res 2005 Feb;29(2):225-8

Section of Haemato-Oncology, Department of Histopathology, Institute of Cancer Research, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, United Kingdom.

View Article
February 2005

Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization.

Cancer Genet Cytogenet 2005 Jan;156(2):122-8

Department of Hematology, Laboratory of Cancer Cytogenetics, Arhus Sygehus, Tage Hansens Gade 2, DK-8000 Arhus C, Denmark.

View Article
January 2005

Familial multiple myeloma.

Authors:
Daniel Catovsky

Haematologica 2005 Jan;90(1):3-4

Institute of Cancer Research, Sutton, Surrey, UK.

View Article
January 2005

MTHFR polymorphisms and risk of chronic lymphocytic leukemia.

Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2268-70

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom.

View Article
December 2004

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

Hematol J 2004 ;5(2):145-51

1Academic Department of Haematology and Cytogenetics, Institute of Cancer Research and Royal Marsden NHS Trust, London, UK.

View Article
November 2004

Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.

Cancer Genet Cytogenet 2004 Oct;154(1):67-71

Academic Department of Haematology and Cytogenetics, Institute of Cancer Research/Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK.

View Article
October 2004

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.

Hematol J 2004 ;5(1):47-54

Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust and Institute of Cancer Research, London, UK.

View Article
September 2004

Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia.

Authors:
Daniel Catovsky

Hematol Oncol Clin North Am 2004 Aug;18(4):783-94, vii

Academic Department of Haematology, The Institute of Cancer Research and Royal Marsden Hospital, 203 Fulham Road, London SW3 6JJ, UK.

View Article
August 2004

B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.

Br J Haematol 2004 May;125(3):330-6

Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London, UK.

View Article
May 2004

The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.

Haematologica 2004 Mar;89(3):303-8

Academic Department of Hematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London, UK.

View Article
March 2004

Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.

Am J Clin Pathol 2003 Nov;120(5):754-9

Academic Department of Haematology and Cytogenetics, Royal Marsden NHS Trust, Institute of Cancer Research, London, England.

View Article
November 2003